ANUH PHARMA
Back to Cashflow Statement
|
ANUH PHARMA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-26 Cr | ₹-4.86 Cr | ₹-8.57 Cr | ₹-12 Cr | ₹-19 Cr |
What is the latest Cash Flow from Financing Activities ratio of ANUH PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-26 Cr |
| Mar2025 | ₹-4.86 Cr |
| Mar2024 | ₹-8.57 Cr |
| Mar2023 | ₹-12 Cr |
| Mar2022 | ₹-19 Cr |
How is Cash Flow from Financing Activities of ANUH PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-26 Cr | Negative | |
| Mar2025 | ₹-4.86 Cr | Negative | |
| Mar2024 | ₹-8.57 Cr | Negative | |
| Mar2023 | ₹-12 Cr | Negative | |
| Mar2022 | ₹-19 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹786.7 Cr | -0.1% | -4.2% | -13.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | -0.1% |
-4.2% |
-13.6% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses